Stocks ticked lower amid adverse developments in the Russia-Ukraine conflict. Failed negotiations between the two sides were cause for concern this morning, raising the...
Biotech companies are difficult to evaluate or analyze due to the speculative nature of their technologies and due to the breadth of knowledge, experience,...
Stocks plunged while oil prices surged and volatility heightened, heading into today’s session as markets processed Russia’s intensifying attacks on Ukraine. The move away...